Product Program year 2023 Source: CMS Open Payments

Avar

Drug Antibacterial (topical)

NDC 0178-0480-08

Open in the dashboard

General payments

$23,074

1,493 payments

Research payments

$0

0 payments

Through program year 2023, $23,074 in general payments and $0 in research payments were reported against Avar (Antibacterial (topical)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2023 General $74 5
2022 General $3,654 223
2021 General $6,228 429
2020 General $3,519 220
2019 General $9,598 616

Breakdown

Who paid General payments · program years 2019–2023
  1. Mission Pharmacal Company $23,074 1,493 payments
Top recipients General payments · program year 2023
  1. Marjorie Gwynn Glen Burnie, MD $16 21% · 1 payment
  2. Chikoti Wheat Dermatology · Glen Burnie, MD $16 21% · 1 payment
  3. Rebekah Chen Physician Assistant · Glen Burnie, MD $16 21% · 1 payment
  4. Kimberly Comeau Physician Assistant · Swampscott, MA $14 18% · 1 payment
  5. Theresa Fukuda Physician Assistant, Medical · Boston, MA $14 18% · 1 payment

Each share is of general payments naming this product in 2023.

Specialties paid General payments · program year 2023
  1. Physician Assistant $29 50% · 2 practitioners
  2. Dermatology $16 27% · 1 practitioner
  3. Physician Assistant, Medical Physician Assistant $14 23% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. Maryland $47 63% · 3 recipients
  2. Massachusetts $27 37% · 2 recipients

Each share is of general payments naming this product in 2023 where a state was reported.

1,493 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record